Back to Authors

Favre-Kontula, Linda

A5004552961 | I4210091812

Mayo Clinic

Bristol-Myers Squibb (United States)

Citations 2

B08 IDECABTAGENE VICLEUCEL VERSUS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA: KARMMA-3 A PHASE 3 RANDOMIZED CONTROLLED TRIAL

HemaSphere | May 10, 2023 | Volume: 7 | Issue: S2 | Pages: 7-8

10.1097/01.hs9.0000936124.56965.24

Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma

New England Journal of Medicine | February 10, 2023 | Volume: 388 | Issue: 11 | Pages: 1002-1014

10.1056/nejmoa2213614 | PMID 36762851